Trinity Biotech Plc Asset Turnover Ratio (TRIB), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Trinity Biotech Plc  (NASDAQ: TRIB)
 

Trinity Biotech Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Trinity Biotech Plc's asset turnover ratio, the ratio that measures the ability of Trinity Biotech Plc's assets to generate revenue, sequentially decreased to 0.43 in the fourth quarter (Dec 31 2025), which does not come as a surprise, as the Trinity Biotech Plc continue to experience difficult business climate.

Within sector 11 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 3458.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TRIB Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -10.47 % 1.46 % 10.18 % 1.46 % 63.23 %
Y / Y Revenue Change -28.87 % - - - 8.31 %
Asset Turnover Ratio (TTM) 0.43 - - - 0.6
TRIB's Total Ranking # 3458 # 0 # # #
Seq. Asset Change 0 % 0 % 0 % -10.47 % 13.33 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 12
Healthcare Sector # 509
Overall Market # 3458

Asset Turnover Ratio Statistics
High Average Low
3.37 3.02 2.33
(Dec 31 2020)   (Dec 31 2025)




TRIB Company Profile • Back to TRIB Efficiency Comparisons • Compare TRIB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
The Pennant Group Inc   1.18 $ 947.705  Millions$ 804.215  Millions
Mettler toledo International Inc   1.16 $ 4,026.399  Millions$ 3,467.314  Millions
Medicure Inc   1.16 $ 22.103  Millions$ 19.111  Millions
Avita Medical Inc   1.16 $ 71.610  Millions$ 61.953  Millions
Precision Optics Corporation Inc   1.15 $ 24.416  Millions$ 21.173  Millions
Pro dex Inc   1.15 $ 72.101  Millions$ 62.739  Millions
Universal Health Services Inc   1.14 $ 17,364.829  Millions$ 15,183.131  Millions
Tandem Diabetes Care Inc   1.14 $ 1,011.039  Millions$ 888.411  Millions
Inogen Inc   1.14 $ 348.668  Millions$ 306.522  Millions
Puma Biotechnology Inc   1.13 $ 228.371  Millions$ 202.565  Millions
Inspire Medical Systems inc   1.12 $ 911.756  Millions$ 812.009  Millions
Healthlynked Corp  1.12 $ 2.065  Millions$ 1.843  Millions
Organogenesis Holdings Inc   1.11 $ 564.169  Millions$ 509.270  Millions
Tela Bio Inc   1.10 $ 79.341  Millions$ 71.948  Millions
Angiodynamics Inc   1.10 $ 305.655  Millions$ 277.836  Millions
Lifeloc Technologies Inc   1.10 $ 9.027  Millions$ 8.207  Millions
Nuwellis Inc   1.09 $ 8.270  Millions$ 7.577  Millions
Harvard Bioscience Inc   1.08 $ 85.910  Millions$ 79.489  Millions
Phibro Animal Health Corporation  1.08 $ 1,465.016  Millions$ 1,356.146  Millions
Esperion Therapeutics Inc   1.07 $ 403.135  Millions$ 375.255  Millions
Myomo Inc   1.07 $ 40.888  Millions$ 38.063  Millions
Axogen inc   1.07 $ 225.208  Millions$ 209.926  Millions
Vaso Corporation  1.07 $ 89.096  Millions$ 83.330  Millions
Apellis Pharmaceuticals Inc   1.07 $ 1,003.782  Millions$ 940.664  Millions
Treace Medical Concepts Inc   1.06 $ 212.690  Millions$ 199.865  Millions
Myriad Genetics Inc   1.06 $ 823.600  Millions$ 779.525  Millions
Neuronetics Inc   1.05 $ 148.308  Millions$ 140.914  Millions
Premier Air Charter Holdings Inc   1.05 $ 31.878  Millions$ 30.459  Millions
Rigel Pharmaceuticals Inc  1.03 $ 294.282  Millions$ 284.709  Millions
Regen Biopharma Inc   1.03 $ 0.237  Millions$ 0.229  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.